Ying Liu

Associate Director, Cell Culture & Process Development, Genomic Medicine Unit Sanofi

Seminars

Thursday 25th February 2027
Evolving AAV Manufacturing: Comparing Transient Transfection & Producer Cell Line Platforms to Enable Scalable Gene Therapy Production
9:00 am
  • Managing transient transfection variability at scale to improve manufacturing consistency, reduce operational complexity and support reliable pipeline delivery
  • Comparing transient transfection and producer cell line platforms to inform technology selection decisions based on technical, operational and economic requirements
  • Optimizing producer cell line clone selection workflows through scale-down screening models to accelerate high-performing clone identification and process development
Ying Liu